Does RITUXIMAB Cause Lymphoproliferative disorder? 96 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Lymphoproliferative disorder have been filed in association with RITUXIMAB (Rituxan). This represents 0.1% of all adverse event reports for RITUXIMAB.
96
Reports of Lymphoproliferative disorder with RITUXIMAB
0.1%
of all RITUXIMAB reports
26
Deaths
29
Hospitalizations
How Dangerous Is Lymphoproliferative disorder From RITUXIMAB?
Of the 96 reports, 26 (27.1%) resulted in death, 29 (30.2%) required hospitalization, and 10 (10.4%) were considered life-threatening.
Is Lymphoproliferative disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Lymphoproliferative disorder?
METHOTREXATE (1,392)
INFLIXIMAB (225)
PREDNISOLONE (178)
PREDNISONE (141)
TACROLIMUS (139)
MYCOPHENOLATE MOFETIL (138)
CYCLOPHOSPHAMIDE (136)
AZATHIOPRINE (120)
ADALIMUMAB (98)
CYCLOSPORINE (98)
Which RITUXIMAB Alternatives Have Lower Lymphoproliferative disorder Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE